Trilaciclib G1T28-04 - Phase 2 Study of the Safety, Efficacy, and Pharmacokinetics of G1T28 in Patients with Metastatic Triple Negative Breast Cancer Receiving Gemcitabine and Carboplatin Chemotherapy.

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/17 → 1/1/20

Funding

  • G1 Therapeutics, Inc.